CareToLive RSS
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Spread The Word
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Donations
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
Posts Tagged ‘Memorial Sloan Kettering’
Provenge is approved!
- Provenge has been approved! Thank you to all who helped achieve this important milestone for cancer patients.
LATEST POSTS
- 02/06/2012 - Great Provenge News Released At ASCO
- 11/27/2011 - Care To Live Board Member Ted Girgus Dies of Prostate Cancer
- 09/06/2011 - Care To Live Update on SEC OIG Investigation into April 28, 2009 Dendreon Bear Raid
- 07/13/2011 - 3 Minute Video Explaining Provenge Treatment
- 06/20/2011 - Abigail Alliance Plans FDA PROTEST June 28
- 06/09/2011 - RIP Charles A. Reinwald — Cancer Cure Coalition Founder
- 04/29/2011 - Care To Live Submits Moment of Silence to CMS
- 04/28/2011 - HHS Desperately Needs Transparency Lessons From CMS
- 04/23/2011 - Please Post for Provenge!
- 04/19/2011 - Another Interim Provenge Prostate Cancer Immunotherapy CMS FOIA Response
MOST POPULAR
- Setting the Record Straight
- Provenge Is Approved But The Lies Continue
- Provenge Works & Costs the Same as Chemo & Comments by Bishop
- The Bloodshed, Bogus Threats, Birth Defects, Bashers Cover Letter
- PROVENGE WILL BE COVERED BY MEDICARE
- CareToLive sends a Freedom of Information Request to the Centers for Medicare & Medicaid Services
- ASCO Tells CMS It Should Cover Provenge
- The Centers for Medicare and Medicaid Services are requesting comments.
- Dr. Snuffy Myers Advocates For Provenge Treatment
- Senators Specter and Kerry - CMS Has Some 'Splaining To Do
WHATS GOING ON
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
WE'LL BE BACK
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.

Care To Live Gets More Specific
January 10th, 2011 | Posted by Mike KearneyAlthough the Court of Appeals decision did not go our way in the case of CTL vs. FDA, whereby we are seeking documents Richard Pazdur declared he shredded and deleted, the Court was kind enough to inform us that our initial request was not specific enough. Therefore Care To Live has filed a new Freedom of Information Act (FOIA) request, which is on its way to the FDA’s Division of Freedom of Information as I post this.
CTL is asking for all documents and e-mails, among other things, sent to and from Richard Pazdur during the period October 1, 2006 through October 1, 2007, inclusive. CTL is quite specific this time in detailing exactly what we are asking them to search for.
The new FOIA request can be seen here:
ctl-cder-foia-request.pdf
Popularity: 15%
Tags: Abiraterone, Alison Martin, Andrew Von Eschenbach, ASCENT1, Asentar, CB7630, Celia Witten, Christopher Logothetis, Cougar, Cougar Biotechnology, Dendreon, Dendrion, Donald Berry, Eric Small, Gardiner Harris, Howard R. Soule, Howard Scher, Howard Streicher, James Mulé, Jay Moorin, Jesse Goodman, Jonathan Simons, Karen Midthun, M.D. Anderson, maha hussain, Mary Foulkes, Matthew Herper, Memorial Sloan Kettering, Michael Milken, novacea, Paul Goldberg, PCF, Proquest Investments, Prostate Cancer Foundation, Salam Jafer Hussain, Savio Lau-Ching Woo, Schering-Plough, sipuluecel-T. Provenge, Stephen Lieberman, Steven Rosenberg, the University of Michigan Comprehensive Cancer Center, the University of Washington., Thomas Fleming, Vincent DeVita, “The Cancer Letter”
Posted in The Cause | 2 Comments »
Provenge Works! What The Heck Is The FDA Waiting For?
April 6th, 2010 | Posted by CTLDear FDA,
As you read this on your next visit here, why not just agree to meet with us in person.
Are you aware Ms. Midthun refused our request to meet with her?
Here is her reply:
http://caretolive.com/2010-01-11/cber-responds-to-letter-from-caretolive/
If you are interested in how we feel and what we seek to accomplish, then PLEASE meet with us.
We are planning a demonstration at the FDA in front of your building as that is the only alternative left to get your attention. We are sure you will see that news here first….so until next time…..
We know you are watching us. What are you looking for? Better yet, what are you waiting for?
CareToLive set up this website in June 2007. It was an information site for people protesting the FDA’s poor decision to delay getting Provenge, a safe and effective, non-toxic immunotherapy for men with late stage prostate cancer. These men are dying in excruciating pain and have no other viable treatment option.
Provenge met the criteria for approval as it has proven survival, the gold standard for approval. A panel of FDA hand-picked experts voted Provenge safe, 17-0, and that it demonstrated substantial evidence of efficacy, 13-4.
CareToLive watched as people approached the last FDA Commissioner, Andrew Von Eschenbach, and asked him to reconsider the decision. They gave him some very good reasons. Mr. Von Eschenbach refused. CareToLive incorporated, filed a Citizen’s Petition, and then a lawsuit, and challenged the FDA decision. CareToLive spelled out why Provenge was not given proper due process by the FDA when it processed the Biologic License Application (BLA).
In July 2007 the FDA visited this site. What was it looking for? It was very late at night, around 10:30. Who was at the FDA office and what were they looking for over here? Is that when they gathered to shred and delete documents in response to our lawsuit?
Here is a list for the past seven months when the FDA stopped by this website.
The FDA stopped by:
09/01/09
10/06/09
10/23/09
10/28/09
11/23/09
12/04/09
12/28/09
12/29/09
12/30/09
01/03/10
01/19/10
01/20/10
01/21/10
02/25/10
03/11/10
03/25/10
The NIH stopped by
12/02/09
Memorial Sloan-Kettering stopped by
12/04/09
12/28/09
Once again, what is the FDA looking for? More important, what is the FDA waiting for? If they read our blogs they saw the latest data presentation from Dendreon, the manufacturer of Provenge. It demonstrates the same safe profile and the survival advantage is better than anything available, by leaps and bounds. What are you waiting for FDA? Approve Provenge NOW!
Popularity: 13%
Tags: cancer, CareToLive, Dendreon, FDA, Howard Scher, Immunotherapy, Josh Sharfstein, Karen Midthun, Kerry M. Donahue, Memorial Sloan Kettering, NCI, NIH, Prostate Cancer, provenge, Richard Pazdur
Posted in The Dysfunctional FDA | Post a Comment »
CareToLive v. FDA — Sixth Circuit Court Grants Oral Argument in Appeal!
June 4th, 2008 | Posted by CTLThe Sixth Circuit Court in Cincinnati, Ohio has granted the request of CareToLive to present oral argument in Appeal No. 07-4465 which is the appeal of the Southern District of Ohio Court decision (case # 07-729).
Oral arguments will be heard on July 29th at 1:30 pm at the Potter Stewart United States Court House, 100 East Fifth St., Cincinnati, Ohio.
Argument will be before a three judge panel. The identity of the three judge panel will not be identified until two weeks before the oral argument date.
Also, Thanks to all the participants that helped make the first ever Coast to Coast prostate cancer demonstrations a huge success!
Continue Reading CareToLive v. FDA — Sixth Circuit Court Grants Oral Argument in Appeal! »
Popularity: 17%
Tags: AIPC, Alison Martin, Brachytherapy, Cancer Vaccine, Care To Live, CareToLive, Chemotherapy, commissioner Andrew Von Eschenbach, Dendreon, FDA, foia, Freedom of Information Act, hormone refractory, Howard Scher, Immunotherapy, Jesse Goodman flubs it, Kerry Donahue, maha hussain, Memorial Sloan Kettering, Michael Milken sadly remains silent, Mike Milken, oncologist, Prostate Cancer, Prostate Gland, Prostatectomy, provenge, Richard Pazdur, Rick Pazdur, Robotic Surgery, Ted Girgus, The Prostate Cancer Foundation stays silent, Thomas R Fleming
Posted in The Cause, The Dysfunctional FDA, The Lawsuit | 5 Comments »